Klinikum St. Georg gGmbH — Clinical Trial Site

17 Registered trials

9 Currently recruiting

Organisation

Klinikum St. Georg gGmbH

Location

Leipzig, Germany

Identifier

ORG-100020655

Address

Delitzscher Strasse 141, Eutritzsch, 04129, Germany

Departments

Clinic for Gastroenterology, Hepatology, Diabetology and Endocrinology
D10-513: Nephrology
Gynäkologie und Geburtshilfe
IDCL (ImmunodeficiencyCenter Leipzig)
Infectious diseases
Internist. Onkologie/Hämatologie
Klinik für Allgemein-, Viszeral-, Thorax- und Gefäßchirurgie
Klinik für Anästhesiologie, Intensiv- und Schmerztherapie
Klinik für Gastroenterologie, Hepatologie, Diabetologie und Endokrinologie
Klinik für Gynäkologie und Geburtshilfe
Klinik für Kinder- und Jugendmedizin
Klinik für Nephrologie
Klinik für Strahlentherapie und Radioonkologie
Klinikum St. Georg - Gynäkologie und Geburtshilfe
Onkologie und Hämatologie
paediatric rheumatology

Clinical trials at this site (17)

Search interface

Safety, tolerability, pharmacokinetics, and efficacy of filgotinib for the treatment of polyarticular-course juvenile idiopathic arthritis i… Recruiting

2024-511593-70-00 Polyarticular-course juvenile idiopathic arthritis 5 2026-04-27
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN). Recruiting

2024-514135-17-00 Immunoglobulin A Nephropathy 5 2024-11-28
Ulcerative Colitis: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects with Moderately to Severely Active Ulcerati… Recruiting

2022-501788-41-00 Ulcerative Colitis 5 2023-11-14
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Subjects With Primary Membranous Nephropathy Recruiting

2025-521661-27-00 Primary Membranous Nephropathy 10 2025-12-19
Pre-Operative Treatment in rEseCTable cOlon canceR (PROTECTOR/FIRE-10; AIO-KRK-0620; IAG-VO-0323) Prospective, randomized, open-label, multi… Recruiting

2023-508076-11-00 Colon cancer staged T3-4 and/or nodal positive by CT an 5 2025-04-01
Role of Pancreatic Enzyme Replacement Therapy (PERT) (Creon®) for Pancreatic Exocrine Insufficiency (PEI) after Pancreatic Surgery Recruiting

2024-512798-29-00 Male and female patients aged ≥ 18 to ≤ 85 years with a 5 2025-01-07
Staphylococcus aureus Network Adaptive Platform trial (SNAP) Recruiting

2023-503582-35-00 Staphylococcus aureus bacteremia 6 2023-10-26
The Pancreatic Enzymes after Gastrectomy Trial Recruiting

2022-501944-14-00 Patients after gastrectomy (total and partial) 5 2023-10-02
Cholangiocarcinoma treatment with radiofrequency ablation or photodynamic therapy Recruiting

2022-500107-50-00 hilar cholangiocarcinoma 6 2022-10-12
Combination of Abemaciclib and endocrine therapy in hormone receptor positive HER2 negative locally advanced or metastatic breast cancer wit… Ended

2024-511209-49-00 Patients with hormone receptor positive HER2 negative l 6 2022-04-26
A randomized, controlled, open-label, phase III-trial on Adjuvant Dynamic marker - Adjusted Personalized Therapy comparing abemaciclib combi… Ended

2023-509242-35-00 HR+/HER2- early breast cancer 5 2020-07-23
Short course radiotherapy versus chemoradiotherapy, followed by consolidation chemotherapy, and selective organ preservation for MRI-defined… Ended

2024-511577-29-01 intermediate and high-risk rectal cancer 5 2020-03-13
Adjuvant Dynamic marker - Adjusted Personalized Therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate-risk… Ended

2024-515769-32-00 HR+/HER2- early breast cancer 5 2019-07-02
VItamin C in Thermal injuRY: The VICToRY Trial A phase III multi-center randomized trial Ended

2023-504772-21-00 Severely burned patients 4 2022-11-22
Zibotentan and Dapagliflozin combination, Evaluated in Liver cirrhosis (ZEAL study) Ended

2023-505405-17-00 Liver cirrhosis with features of portal hypertension. 4 2022-10-07
Prospective, open-label, single-arm, multicentre Phase 3 study to evaluate the pharmacokinetics, efficacy, tolerability, and safety of subcu… Ended

2024-511231-94-00 Human Normal Immunoglobulin 5 2021-10-27
CIRCULATE Ended

2023-506715-18-00 colon cancer stage II, rectal cancer stage II 5 2019-12-04